Hannes Buck

Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10).

M. Foley, M. Fushimi, N. Liverton, 2021, ACS medicinal chemistry letters.

Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase

C. Steegborn, J. van den Heuvel, L. Levin, 2016, Nature chemical biology.

Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential

C. Steegborn, R. Myers, L. Levin, 2022, Frontiers in Physiology.

Bithionol Potently Inhibits Human Soluble Adenylyl Cyclase through Binding to the Allosteric Activator Site*

Laureen C. Colis, C. Steegborn, J. van den Heuvel, 2016, The Journal of Biological Chemistry.